RE: IPO Price29 May 2025 10:55
The company haven't ever given a suggested price target. There was a lot of discussion on the board when the SPAC news first came out about potential market cap. NASDAQ listing rules have a minimum market cap for SPAC transactions, which from memory is either $50m or $80m, depending on what part of the exchange you are listing on (NASDAQ Capital Market or NASDAQ Global Market) and what other standards (other than the market value standard) you can meet e.g. income standard, total assets standard. I think most on here have assumed that $50m is the minimum market value rule that applies in our case, and Alex may have also hinted at this on a call a few months ago.
So that may be the minimum value, but based on previous Cohen & Co precedent transactions (listed in the 27th Nov 2024 RNS) it looks unlikely that we will need to worry about the minimum. Guesstimates on this board seem to be in the $100-400m range, and I think $100m would be a good conservative guess. My more bullish side would be $200m, with Mkango retaining 75% and the other 25% covering Cohen's and other fees, CrownProptech's share and an initial raise on relisting of the SPAC entity of say $20m. Obviously relevant news e.g. EU CRMA status for Songwe, further China RE restrictions, change in RE pricing would all influence the value.
In terms of dates, we know that the directors need the listing to happen by the end of the year as 40% of their options are linked to achieving this milestone. Working backwards the general consensus is that this means a business combination agreement and initial valuation needs to be completed by the end of June, or July at the latest (though this would leave very little wiggle room).